Logo

Bruker: Philip Ma

Mar 17, 2022

Bruker has appointed Philip Ma to its board of directors. Ma is the CEO, founder, and a director of PrognomiQ, a multiomics diagnostics firm developing tests for the early detection of cancer and guiding cancer treatments. Ma was previously chief business officer, president, and co-founder of proteomics company Seer, which is an investor in PrognomiQ. Before that he was vice president for digital health technologies and data sciences at Biogen.

Breaking News
The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.